Culturing Human Embryonic Stem Cells in Feeder-Free Conditions
Continue Reading
Culturing Human Embryonic Stem Cells in Feeder-Free Conditions
Noninvasive Human Nuclear Transfer with Embryonic Stem Cells
Continue Reading
Noninvasive Human Nuclear Transfer with Embryonic Stem Cells
Culturing human embryonic stem cells with mouse embryonic fibroblast feeder cells
Continue Reading
Culturing human embryonic stem cells with mouse embryonic fibroblast feeder cells
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure
Patients with end-stage heart failure (ESHF) have a 2-year survival rate of 50% with conventional medical therapy. This dismal survival rate is actually significantly worse than patients with AIDS, liver…
Continue Reading
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure
Embryonic stem cells derived from in vivo or in vitro-generated murine blastocysts display similar transcriptome and differentiation potential.
The use of assisted reproductive technologies (ART) such as in vitro fertilization (IVF) has resulted in the birth of more than 5 million children. While children conceived by these technologies…
Continue Reading
Embryonic stem cells derived from in vivo or in vitro-generated murine blastocysts display similar transcriptome and differentiation potential.
Inner ear hair cell-like cells from human embryonic stem cells.
In mammals, the permanence of many forms of hearing loss is the result of the inner ear's inability to replace lost sensory hair cells. Here, we apply a differentiation strategy…
Continue Reading
Inner ear hair cell-like cells from human embryonic stem cells.
CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells.
The generation of tissue-specific cell types from human embryonic stem cells (hESCs) is critical for the development of future stem cell-based regenerative therapies. Here, we identify CD13 and ROR2 as…
Continue Reading
CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells.
Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy.
AIM: To enumerate and characterize mesenchymal stem cells (MSC) derived from human embryonic stem cells (hESC) for clinical application. MATERIALS & METHODS: hESC were differentiated into hESC-MSC and characterized by…
Continue Reading
Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy.